Eric M. Green is the President and Chief Executive Officer of West Pharmaceutical Services Inc., a leading global manufacturer of packaging components and delivery systems for injectable drugs. With a robust background in the pharmaceutical industry, Green has been instrumental in steering the company towards significant growth and innovation. He joined West Pharmaceutical Services in 2014 as the Chief Operating Officer before being promoted to his current role in 2019. Prior to joining West, Green held various leadership positions at Covidien, now part of Medtronic, where he honed his skills in operations and strategic management. Under Green's leadership, West Pharmaceutical Services has seen a notable expansion in its product portfolio and market reach. He has been pivotal in driving the company's focus on developing high-value products such as the proprietary HVP (High-Value Product) technologies, which have significantly increased the company's revenue streams. Green's strategic vision has also led to the establishment of new manufacturing facilities globally, enhancing the company's capability to serve a broader customer base. His commitment to innovation is evident in the company's increased investment in research and development, aiming to address the evolving needs of the pharmaceutical industry. In addition to his operational achievements, Eric M. Green is known for his dedication to corporate social responsibility. He has championed initiatives that promote sustainability and ethical business practices within West Pharmaceutical Services. Green's leadership style emphasizes collaboration and inclusivity, fostering a corporate culture that values diversity and employee engagement. His efforts have not only solidified West Pharmaceutical Services' position as a leader in the industry but also ensured that the company remains a responsible and forward-thinking organization.